---
title: "MURRAY MARK ANTHONY — Ownership Dossier"
canonical: https://whiteintel.dev/entity/42f0e0bf-e0bb-571e-a80b-d50c1ba71513
json: https://whiteintel.dev/api/public/dossier/42f0e0bf-e0bb-571e-a80b-d50c1ba71513
identifier: sec:0001791443
jurisdiction: US
risk: Low
source: WhiteIntel corporate-ownership graph
---

# MURRAY MARK ANTHONY

**Type:** Company  
**Jurisdiction:** [US](https://whiteintel.dev/jurisdictions/us)  
**Identifier:** `sec:0001791443`  
**Risk level:** Low  
**Canonical dossier:** https://whiteintel.dev/entity/42f0e0bf-e0bb-571e-a80b-d50c1ba71513  
**Structured JSON / MCP:** https://whiteintel.dev/api/public/dossier/42f0e0bf-e0bb-571e-a80b-d50c1ba71513  

## Ownership & control

### Holdings / subsidiaries

- **OYSTER POINT PHARMA, INC.** (director) — https://whiteintel.dev/entity/5e6eb1ea-5893-580d-adfb-09d9a3272164

---

_This is the markdown-for-agents view of the WhiteIntel dossier for **MURRAY MARK ANTHONY**. Human view: https://whiteintel.dev/entity/42f0e0bf-e0bb-571e-a80b-d50c1ba71513 · Structured JSON: https://whiteintel.dev/api/public/dossier/42f0e0bf-e0bb-571e-a80b-d50c1ba71513._

_Risk levels are heuristic investigative leads, not legal determinations of beneficial ownership. Every claim carries a source; an absent edge means "not yet observed in current sources", not "does not exist"._